001     136732
005     20240321220127.0
024 7 _ |a 10.1523/JNEUROSCI.2681-12.2012
|2 doi
024 7 _ |a pmid:23238734
|2 pmid
024 7 _ |a pmc:PMC6621731
|2 pmc
024 7 _ |a 0270-6474
|2 ISSN
024 7 _ |a 1529-2401
|2 ISSN
024 7 _ |a altmetric:1127812
|2 altmetric
037 _ _ |a DZNE-2020-03054
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Page, Richard M
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Loss of PAFAH1B2 reduces amyloid-β generation by promoting the degradation of amyloid precursor protein C-terminal fragments.
260 _ _ |a Washington, DC
|c 2012
|b Soc.57413
264 _ 1 |3 online
|2 Crossref
|b Society for Neuroscience
|c 2012-12-12
264 _ 1 |3 print
|2 Crossref
|b Society for Neuroscience
|c 2012-12-12
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1589983267_10886
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Amyloid-β peptide (Aβ) is believed to play a central role in the pathogenesis of Alzheimer's disease. In view of the side effects associated with inhibiting the secretases that produce Aβ, new molecular targets are required to provide alternative therapeutic options. We used RNA interference (RNAi) to systematically screen the Drosophila genome to identify genes that modulate Aβ production upon knockdown. RNAi of 41 genes in Drosophila cells significantly lowered Aβ without affecting general secretion or viability. After the γ-secretase complex components, the most potent effect was observed for platelet activating factor acetylhydrolase α (Paf-AHα), and, in mammalian cells, the effect was replicated for its ortholog PAFAH1B2. Knockdown of PAFAH1B2 strongly reduced Aβ secretion from human cells, and this effect was confirmed in primary cells derived from PAFAH1B2 knock-out mice. Reduced Aβ production was not attributable to altered β-amyloid precursor protein (APP) ectodomain shedding but was a result of an enhanced degradation of APP C-terminal fragments (CTFs) in the absence of PAFAH1B2 but not its close homolog PAFAH1B3. Enhanced degradation of APP CTFs was selective because no such effects were obtained for Notch or E-/N-cadherin. Thus, we have identified an important protein that can selectively modify Aβ generation via a novel mechanism, namely enhanced degradation of its immediate precursor. In view of the absence of a neurological phenotype in PAFAH1B2 knock-out mice, targeted downregulation of PAFAH1B2 may be a promising new strategy for lowering Aβ.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
542 _ _ |i 2013-06-12
|2 Crossref
|u https://creativecommons.org/licenses/by-nc-sa/4.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Amyloid beta-Peptides
|2 NLM Chemicals
650 _ 7 |a Amyloid beta-Protein Precursor
|2 NLM Chemicals
650 _ 7 |a Microtubule-Associated Proteins
|2 NLM Chemicals
650 _ 7 |a Peptide Fragments
|2 NLM Chemicals
650 _ 7 |a 1-Alkyl-2-acetylglycerophosphocholine Esterase
|0 EC 3.1.1.47
|2 NLM Chemicals
650 _ 7 |a PAFAH1B1 protein, human
|0 EC 3.1.1.47
|2 NLM Chemicals
650 _ 2 |a 1-Alkyl-2-acetylglycerophosphocholine Esterase: genetics
|2 MeSH
650 _ 2 |a 1-Alkyl-2-acetylglycerophosphocholine Esterase: metabolism
|2 MeSH
650 _ 2 |a Amyloid beta-Peptides: metabolism
|2 MeSH
650 _ 2 |a Amyloid beta-Protein Precursor: metabolism
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Drosophila
|2 MeSH
650 _ 2 |a Gene Knockdown Techniques
|2 MeSH
650 _ 2 |a HEK293 Cells
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Mice, Knockout
|2 MeSH
650 _ 2 |a Microtubule-Associated Proteins: genetics
|2 MeSH
650 _ 2 |a Microtubule-Associated Proteins: metabolism
|2 MeSH
650 _ 2 |a Peptide Fragments: metabolism
|2 MeSH
650 _ 2 |a RNA Interference
|2 MeSH
650 _ 2 |a Transfection
|2 MeSH
700 1 _ |a Münch, Anna
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Horn, Thomas
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Kuhn, Peer-Hendrik
|0 P:(DE-2719)2810327
|b 3
700 1 _ |a Colombo, Alessio
|0 P:(DE-2719)2340744
|b 4
700 1 _ |a Reiner, Orly
|b 5
700 1 _ |a Boutros, Michael
|b 6
700 1 _ |a Steiner, Harald
|0 P:(DE-2719)2000023
|b 7
700 1 _ |a Lichtenthaler, Stefan F
|0 P:(DE-2719)2181459
|b 8
700 1 _ |a Haass, Christian
|0 P:(DE-2719)2202037
|b 9
|e Last author
773 1 8 |a 10.1523/jneurosci.2681-12.2012
|b Society for Neuroscience
|d 2012-12-12
|n 50
|p 18204-18214
|3 journal-article
|2 Crossref
|t The Journal of Neuroscience
|v 32
|y 2012
|x 0270-6474
773 _ _ |a 10.1523/JNEUROSCI.2681-12.2012
|g Vol. 32, no. 50, p. 18204 - 18214
|0 PERI:(DE-600)1475274-8
|n 50
|q 32:50<18204 - 18214
|p 18204-18214
|t The journal of neuroscience
|v 32
|y 2012
|x 0270-6474
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6621731
909 C O |p VDB
|o oai:pub.dzne.de:136732
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2810327
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2340744
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2000023
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2181459
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2202037
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2012
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROSCI : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J NEUROSCI : 2017
920 1 _ |0 I:(DE-2719)1110006
|k AG Lichtenthaler
|l Neuroproteomics
|x 0
920 1 _ |0 I:(DE-2719)1110000-1
|k AG Steiner
|l Biochemistry of γ-Secretase
|x 1
920 1 _ |0 I:(DE-2719)1110007
|k AG Haass old
|l ALS, FTLD and Zebrafish models
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1110006
980 _ _ |a I:(DE-2719)1110000-1
980 _ _ |a I:(DE-2719)5000015
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1093/oxfordjournals.jbchem.a003145
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1091/mbc.E09-12-1064
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0021-9258(19)70115-X
|9 -- missing cx lookup --
|1 Blank
|p 175 -
|2 Crossref
|t J Biol Chem
|v 256
|y 1981
999 C 5 |a 10.1038/nrg2364
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1126/science.1091266
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1186/gb-2006-7-7-r66
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.nbd.2008.10.014
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0021-9258(19)39742-X
|9 -- missing cx lookup --
|1 Chen
|p 3116 -
|2 Crossref
|t J Biol Chem
|v 265
|y 1990
999 C 5 |a 10.1038/nrd2896
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/360672a0
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |1 Colombo
|y 2012
|2 Crossref
|o Colombo 2012
999 C 5 |a 10.1073/pnas.132277899
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/ncb960
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1073/pnas.95.23.13703
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1523/JNEUROSCI.0283-04.2004
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/sj.emboj.7600061
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/nrm2101
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/357500a0
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0021-9258(18)53650-4
|9 -- missing cx lookup --
|1 Haass
|p 3021 -
|2 Crossref
|t J Biol Chem
|v 268
|y 1993
999 C 5 |a 10.1038/nm1295-1291
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0021-9258(17)46693-2
|9 -- missing cx lookup --
|1 Hattori
|p 18748 -
|2 Crossref
|t J Biol Chem
|v 268
|y 1993
999 C 5 |a 10.1038/nature09325
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1186/gb-2010-11-6-r61
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1385/MN:30:2:185
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M211836200
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/emboj.2010.167
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1111/j.1471-4159.2010.07081.x
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0014-5793(99)00730-9
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |1 Livnat
|y 2010
|2 Crossref
|o Livnat 2010
999 C 5 |a 10.1186/1756-6606-3-11
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1073/pnas.0605461103
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1093/emboj/cdf541
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M708754200
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M110.103283
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1523/JNEUROSCI.1026-07.2007
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1126/science.273.5279.1227
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1126/science.287.5461.2204
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/30756
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1111/j.1749-6632.1996.tb34401.x
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1002/(SICI)1097-0134(20000401)39:1<1::AID-PROT1>3.0.CO;2-N
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M110.102277
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1073/pnas.1230693100
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/35041097
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.R800010200
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |1 Tarricone
|y 2004
|2 Crossref
|o Tarricone 2004
999 C 5 |a 10.1126/science.1160649
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.R800019200
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1073/pnas.1236145100
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1371/journal.pone.0000252
|9 -- missing cx lookup --
|2 Crossref


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21